Product NDC: | 24979-514 |
Proprietary Name: | Divalproex Sodium |
Non Proprietary Name: | Divalproex Sodium |
Active Ingredient(s): | 500 mg/1 & nbsp; Divalproex Sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 24979-514 |
Labeler Name: | Anchen Pharmaceuticals (Taiwan), Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078411 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110601 |
Package NDC: | 24979-514-50 |
Package Description: | 500 TABLET, DELAYED RELEASE in 1 BOTTLE (24979-514-50) |
NDC Code | 24979-514-50 |
Proprietary Name | Divalproex Sodium |
Package Description | 500 TABLET, DELAYED RELEASE in 1 BOTTLE (24979-514-50) |
Product NDC | 24979-514 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Divalproex Sodium |
Dosage Form Name | TABLET, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20110601 |
Marketing Category Name | ANDA |
Labeler Name | Anchen Pharmaceuticals (Taiwan), Inc. |
Substance Name | DIVALPROEX SODIUM |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |